Latest News

Indoco Remedies gets accreditation renewal from Japanese authorities

Indoco Remedies has received accreditation renewal, from Japanese regulatory authorities.

The company is a fully integrated, research oriented pharma company engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs).

Furthermore, the company’s API plant which is located at Patalganga, has received accreditation renewal from the Japanese regulatory authorities. The accreditation is valid until May 21,2023.

Read EquityPandit’s Technical Analysis of Nifty Pharma

Click here to check market prediction for next trading session.

Get Daily Prediction & Stocks Tips On Your Mobile


I would like to receive communication from EquityPandit via sms, email, whatsapp, Google RCS for offers, updates etc.



📰
News
📈
Prediction
📊
FII / DII
👔
Advisory
Get 1-2 Index Option Trades Daily